The Liver - PowerPoint PPT Presentation

1 / 34
About This Presentation
Title:

The Liver

Description:

Tattoos / Piercing. Neonatal 5% Shared House-hold items ... Rule out heart, lung, eye or any serious disease. 24. Side-effects. Interferon. Fatigue ... – PowerPoint PPT presentation

Number of Views:104
Avg rating:3.0/5.0
Slides: 35
Provided by: hep7
Category:
Tags: heart | liver | tattoos

less

Transcript and Presenter's Notes

Title: The Liver


1
The Liver
  • Largest internal organ
  • Approximately 3 lbs (men)
  • Size of a football
  • 1.5 quarts of blood flow through it every minute

2
Liver Functions
  • Bile
  • Immune System
  • Chemical Factory-
  • gt500 chemical functions
  • Detoxifies
  • Clotting Factors
  • Hormones

Regenerates Itself!
3
Keep Your Liver Healthy (Healthy People)
  • No more than 2 alcoholic drinks daily
  • Be cautious about mixing drugs especially with
    alcohol
  • Healthy, balanced diet
  • Get HAV HBV vaccinations
  • Avoid toxic substances / fumes

4
(No Transcript)
5
Some Statistics
  • 3 of world has HCV (150-200 million)
  • 4 Million in U.S. infected with HCV
  • 10,000 in U.S. die of complications from HCV in
    10 years will triple
  • HCV is the leading cause for liver transplants
  • 55-80 of HCV infected become chronic

6
More Statistics
  • U.S. Population
  • 1.8 overall
  • 2.1 Mexican-Americans
  • 3.4 African Americans
  • California
  • 500,000 infected with HCV
  • 85-95 - IDUs
  • Prisons 63,500 inmates infected or (41)

7
What Does It Mean?
  • Only 10-30 progress on to serious liver disease
  • Treatment options do work for some
  • Better treatment options within 5 years
  • Lifestyle changes can make a big difference

8
Some HCV History
  • 1948 blood samples stored since 1948
    contain HCV antibodies, earliest
    known
  • 1970s many cases reported called non-A,
    non-B hepatitis
  • 1988 hepatitis C virus identified
  • 1990 antibody screening tests available
  • 1992 better tests to insure safety of blood
    supply

9
Lifecycle
  • Incubation period
  • 2-25 weeks - average 7-9 weeks
  • Virus enter the body
  • Binds enters cell (usually liver receptor)
  • Virus loses lipid coat and polyprotein envelop
    freeing RNA
  • Enzymes in the cell make large viral protein to
    help make new viral RNA
  • Virus releases new virus into blood and
    eventually kills host cell
  • Replication - gt 1 trillion per day

10
Lifecycle (cont)
  • 20-45 of acute case resolve
  • 55-80 of acute cases become chronic
  • Chronic cases may progress on to serious liver
    disease or remain stable

11
Dialogistic Tools
  • Elisa II / Riba Test for anti-body
  • Hepatitis C RNA by PCR - gt50 particles
  • Hep C RNA by branched DNA Assay gt200,000
    particles
  • Genotype (six major subtypes 72 of U.S.
    population have genotype 1)
  • Liver Biopsy

12
Transmission / Prevention
13
Harm Reduction
  • Prevention
  • Needle exchange clean needles and drug
    preparation tools cookers cottons
  • Bleach Does it work?
  • 101
  • Cover wounds

14
HCV CAN NOT BE SPREAD BY
  • BREAST FEEDING
  • SNEEZING
  • HUGGING
  • COUGHING
  • FOOD OR WATER
  • SHARINING EATING UTENSILS OR DRINKING GLASSES
  • CASUAL CONTACT

15
Symptoms
  • Acute vs. Chronic
  • Fatigue mild to severe
  • Flu-like symptoms (muscle/joint/fever)
  • Brain Fog
  • Liver Pain
  • Loss of appetite
  • Headaches
  • Gastro Problems

16
Conditions Linked to HCV
  • Arthritis
  • Autoimmune hepatitis
  • Sjogrens Syndrome
  • Cryoglobulinemia
  • Kidney disease
  • Liver Cancer

17
QUALITY OF LIFE
  • Patients with chronic hepatitis C have a
    significantly reduced quality of life compared to
    those with HIV.
  • Patients with HIV/HCV co-infection quality of
    life is not worse than patients with HCV alone
  • Edmund J Bini, New York AASLD 2000

18
Treatment Medications
  • Interferon by injection - first FDA approved
    treatment (3 mu, thrice weekly for 48 weeks)
  • Genotype 1 - 9 SVR
  • Genotype other than 1 30 SVR

19
Interferon and Ribavirin
  • Interferon and ribavirin(capsule)- combo
    therapy
  • INF 3 mu units, thrice weekly - Ribavirin
    800-1200 mg daily
  • Overall SVR up to 45
  • Genotype 1 12 mos 29 SVR
  • Genotype Non 1 6 mos - 62 SVR

20
Pegylated Interferon
  • Schering- PEG-Intron
  • Approved by FDA 1-2001
  • 24 sustained response rate
  • ROCHE Pegasys FDA approval expected 4-2001
  • 39 sustained response rate

21
Pegylated and Ribavirin
  • Schering PEG-Intron plus ribavirin
  • Phase III clinical data 54 sustained response
    rates
  • Roche Pegasys plus ribavirin
  • Phase II clinical data 70 end of treatment
    response rate
  • 4-2001 report sustained response rates

22
Treatment Decisions
  • General Treatment Guidelines
  • Healthy
  • Active HCV
  • Elevated ALTs
  • Compensated liver disease
  • Optimal Response
  • Younger
  • Female
  • Low viral load
  • Minimal liver damage
  • Genotype other than 1

23
Pre-Treatment Tests
  • Complete Blood Count
  • Liver panel
  • Thyroid function test (TSH,T4)
  • Pregnancy Tests
  • Autoimmune tests
  • Rule out heart, lung, eye or any serious
    disease

24
Side-effects
  • Interferon
  • Fatigue
  • Muscle/Joint pain
  • Nausea
  • Headaches
  • Anxiety
  • Depression
  • Dry Skin/rashes
  • Ribavirin
  • seems to make interferon side effects worse
    especially fatigue-Anemia
  • (both men women must use birth control)

25
Managing Side-Effects
  • Inject before bedtime
  • Drink lots of water
  • Low doses of ibuprofen or acetaminophen
  • Pain medications
  • Light exercise
  • Daily moisturizing
  • Vary injection sites
  • Anti-Depressants
  • Plenty of rest
  • Frequent small meals

26
Monitoring Therapy Potential Problems
  • Neutropenia (low white blood cells)
  • Thrombocytopenia (low platelets)
  • Neumega approved for chemotherapy
  • Anemia
  • Procrit
  • Thyroid disease
  • Depression / anxiety
  • Treat with anti-depressants / anti-anxiety drugs
  • General Health

27
Response to Therapy
  • Decrease (2 log drop) or elimination of virus at
    week 12 is predictive of sustained virologic
    response
  • Histological response
  • Stop Therapy?

28
Experimental Therapies
  • Amantadine - pill
  • Maxamine by injection (phase II studies)
  • Ribozymes
  • Helicase Inhibitors
  • Protease Inhibitors
  • Interleukin-10

29
Clinical Trials
  • Phase I safety tolerability in (healthy
    subjects)
  • Phase II- measures drug efficiency /
    effectiveness
  • Phase III comparing the new drug to standard
    treatment
  • Phase IV refine the treatment for maximum
    effectiveness

30
Benefits of Clinical Trials
  • Pharmaceutical may pick up some or all costs of
    medications, visits, tests
  • Opportunities to try new medications
  • Usually support is good monitoring and access
    to clinical nurse

31
Disadvantages of Clinical Trials
  • Guinea pig
  • May not get optimal medication or dose
  • May withhold information medicine or test
    results
  • Important know your rights!
  • Can never be forced to stay in study

32
Complementary Medicine
  • Herbs milk thistle
  • Always check with your doctor and herbalist
    some herbs are TOXIC
  • Acupuncture / Acupressure
  • Traditional Chinese Medicine

33
Lifestyle Changes That Help!
  • Alcohol - Avoid
  • Get vaccinated Hep A Hep B
  • Healthy balanced diet
  • Exercise
  • Stress Reduction
  • Support Groups

34
Advocate for Yourself!
  • Educate yourself
  • Establish a good relationship with your doctor
  • Bring an advocate for doctors visits
  • Ask questions
  • Keep copies of all medical tests
  • Keep a diary
  • Keep an open mind
Write a Comment
User Comments (0)
About PowerShow.com